Therefore, it is highly desirable to find new anti-diabetic agents that stimulate glucose uptake by adipose or muscle cells but, unlike thiazolidinedione or insulin, do not induce obesity or other side effects [6]. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.